<html>
<head>PUBMED IDs for NCAD</head>
<body bgcolor='#C5F0F2'><h1>NCAD</h1><a href='https://pubmed.ncbi.nlm.nih.gov/2121144/'>Identification of mammalian and invertebrate analogues of the avian calcium-dependent cell adhesion protein N-cadherin with synthetic-peptide directed antibodies against a conserved cytoplasmic domain.</a> October 15  1990<br><a href='https://pubmed.ncbi.nlm.nih.gov/10703921/'>A role for N-cadherin in the development of the differentiated osteoblastic phenotype.</a> March 7  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10703882/'>Angiotensin I to angiotensin II conversion in the human forearm and leg. Effect of the angiotensin converting enzyme gene insertion/deletion polymorphism.</a> March 7  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/15124908/'>Apolipoprotein C3 SstI polymorphism in the risk assessment of CAD.</a> May 6  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/16403951/'>APOA1-75 G to A substitution associated with severe forms of CAD, lower levels of HDL and apoA-I among northern Indians.</a> January 13  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17878224/'>Expression of adrenomedullin in human epicardial adipose tissue: role of coronary status.</a> September 20  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/19685167/'>Butyrylcholinesterase K variant and the APOE-epsilon 4 allele work in synergy to increase the risk of coronary artery disease especially in diabetic patients.</a> June 9  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19921748/'>Characterization of gastrulation-stage progenitor cells and their inhibitory crosstalk in human embryoid bodies.</a> March 2  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/25601961/'>The implication of cigarette smoking and cessation on macrophage cholesterol efflux in coronary artery disease patients.</a> November 17  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25601934/'>Renin, genes, microRNAs, and renal mechanisms involved in hypertension.</a> June 17  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27481099/'>A single aspartate mutation in the conserved catalytic site of Rev3L generates a hypomorphic phenotype in vivo and in vitro.</a> August 3  2016<br></body></html>
